Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting sphingosine kinase 2 (SphK2) by ABC294640 inhibits colorectal cancer cell growth in vitro and in vivo
Authors
Keywords
Colorectal cancer, Sphingosine kinase, ABC294640, Ceramide and signaling
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 34, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-03
DOI
10.1186/s13046-015-0205-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The preclinical evaluation of the dual mTORC1/2 inhibitor INK-128 as a potential anti-colorectal cancer agent
- (2015) Chen Li et al. CANCER BIOLOGY & THERAPY
- ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer
- (2015) Jie Yang et al. CANCER BIOLOGY & THERAPY
- Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation
- (2015) KanKan Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways
- (2014) Barbara Nuvoli et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer
- (2014) Jian-Ming Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Towards improved drugs, combinations and patient selection
- (2014) Hans-Joachim Schmoll et al. Nature Reviews Clinical Oncology
- Adjuvant chemotherapy for rectal cancer—an unresolved issue
- (2014) Manisha Palta et al. Nature Reviews Clinical Oncology
- Inhibition of sphingosine kinase-2 ablates androgen resistant prostate cancer proliferation and survival
- (2014) Matthew M. Gestaut et al. Pharmacological Reports
- Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production
- (2013) Lei Gong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer
- (2013) Giuseppe Tonini et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Sphingolipids: regulators of crosstalk between apoptosis and autophagy
- (2012) Megan M. Young et al. JOURNAL OF LIPID RESEARCH
- C6 pyridinium ceramide influences alternative pre-mRNA splicing by inhibiting protein phosphatase-1
- (2012) Chiranthani Sumanasekera et al. NUCLEIC ACIDS RESEARCH
- Sphingosine Kinase Inhibitors and Cancer: Seeking the Golden Sword of Hercules
- (2011) S. Pyne et al. CANCER RESEARCH
- Sensitization of human colon cancer cells to sodium butyrate-induced apoptosis by modulation of sphingosine kinase 2 and protein kinase D
- (2011) Min Xiao et al. EXPERIMENTAL CELL RESEARCH
- Ablation of Sphingosine Kinase-2 Inhibits Tumor Cell Proliferation and Migration
- (2011) P. Gao et al. MOLECULAR CANCER RESEARCH
- Ceramide in Chemotherapy of Tumors
- (2011) Marie-Therese Dimanche-Boitrel et al. Recent Patents on Anti-Cancer Drug Discovery
- Sphingosine-1-phosphate signaling and its role in disease
- (2011) Michael Maceyka et al. TRENDS IN CELL BIOLOGY
- Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640
- (2010) James W. Antoon et al. ENDOCRINOLOGY
- Pharmacology and Antitumor Activity of ABC294640, a Selective Inhibitor of Sphingosine Kinase-2
- (2010) K. J. French et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- mTOR Signaling Pathway Is a Target for the Treatment of Colorectal Cancer
- (2009) Yan-Jie Zhang et al. ANNALS OF SURGICAL ONCOLOGY
- Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer
- (2009) Anna Isinger Ekstrand et al. Familial Cancer
- Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway
- (2008) C.-L. Chen et al. BLOOD
- Targeting SphK1 as a New Strategy against Cancer
- (2008) Dai Shida et al. CURRENT DRUG TARGETS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now